New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia
Erin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care
By Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp
Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.
Hormone receptor-positive (HR-positive) breast cancer is the most common subtype of invasive breast cancer. Treatment has been focused on targeting the estrogen receptor pathway, and endocrine therapy (ET) has remained the mainstay treatment for these patients.
Improving care for cystic fibrosis patients with pharmacy program
For people living with cystic fibrosis, St. Luke’s is making it easier to keep up, by putting a pharmacy directly in the clinic. A new grant from the Cystic Fibrosis Foundation goes towards implementing a pharmacy program for the center in Boise.
Children are a big deal at St. Luke’s. The $42 million, 100,000-square foot Idaho Elks Children’s Pavilion, which opened this summer in Boise, makes that very clear. But caring for children goes beyond the Children’s Pavilion and extends across the St. Luke’s Health System.
Regional Health today announced it will become Monument Health in January 2020. It will continue to employ more than 4,500 physicians and caregivers in 20 Western South Dakota and Eastern Wyoming communities after the name change.
Improving CF Medication Adherence: A Specialty Pharmacy at Work – Part 1
Patient Care (PC) recently spoke with Sandy ILL, PharmD, CSP, a specialty pharmacist; Kim Ehlert, PharmD, a clinical pharmacist; and Tim Affeldt, PharmD, vice president of specialty pharmacy at Fairview Health Services, a nonprofit, integrated health system based in Minneapolis, Minn, to discuss how they address CF medication adherence in their health system.
Working with Barriers to CF Treatment Adherence, the Fairview Way – Part 2
According to the latest guidelines for cystic fibrosis (CF) published in U.S. Pharmacist, pharmacists are an important part of counseling patients with CF. The Fairview CF medication adherence rate is 70% higher than among patients at retail pharmacies.